Richard Gorlick, MD

MD Anderson Cancer Center
Houston, Texas, United States

Presentation(s):

• Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1

  Saturday, November 19, 2022
  3:38 PM – 3:46 PM

• Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP

  Saturday, November 19, 2022
  4:00 PM – 4:08 PM